Inhibitory Actions of Synthetic Actin Peptides and 2,3-Butanedion Monoxime on Actomyosin System

  • Yoh Okamoto
  • Akihisa Hobo
  • Koichi Kamisawada
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 453)


Interaction of myosin and actin has been studied in the presence of inhibitors in order to identify and characterize sites essential for the motor function. Acidic amino acid cluster of actin at the amino terminal region is known to interact with basic residue around 50K-20K connecting loop of the myosin heavy chain. In this study, an amino terminal peptide region of actin without the initial four acidic residue cluster is also shown to have important role in the interaction with myosin in the presence of ATP. A set of peptides corresponding to actin sequences from Leu8 to Arg28 or to Gly36 were synthesized. In the absence of actin, neither activation nor inhibition of MgATPase activity of S1 alone has been observed with both types of peptide. In the presence of actin, however, the longer peptide (L8G36) at 50 μM shows about 50% inactivation of the control value of actoS1 Mg2+ATPase activity. The shorter one (L8R28) has been a non competitive and weaker inhibitor. The inhibition could be interpreted as a results of impairing of one of the interactions necessary for normal progression of actomyosin ATPase reaction. Moreover, these results indicate a contribution of amino terminal sequence of actin without initial four acidic residues for the acto myosin interaction. Examination of the inhibitory mechanism of BDM has shown that the effect may not be due to lowering the binding affinity between actin and myosin.


ATPase Activity Longe Peptide ATPase Reaction Actin Concentration Amino Terminal Region 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Van Eyk, J. E. Sönnichen, F. D., Sykes, B. D. & Hodges, R. S. in Peptides as Probes in Muscle Research (ed. Rüegg, J. C.) 15–32 (Springer-Verlag, Berlin, 1991)CrossRefGoogle Scholar
  2. 2.
    Kögler, H., Moir, A. J. C, Trayer, I. R & Rüegg, J. C. FEBS Letters 294, 31–34 (1991)CrossRefGoogle Scholar
  3. 3.
    Labbé, J-R, Boyer, M, Méjean, C., Roustan, S., & Benyamin, Y. Eur. J. Biochem. 215, 17–24 (1993)PubMedCrossRefGoogle Scholar
  4. 4.
    Johara, M., Toyoshima, Y. Y., Ishijima, A. Kojima, H., Yanagida, T. & Sutoh, K. Proc. Natl. Acad. Sci. USA 90, 2127–2131 (1993)PubMedCrossRefGoogle Scholar
  5. 5.
    Spudich, J. A. & Watt, S. J. Biol. Chem. 246, 4866–4871 (1971)PubMedGoogle Scholar
  6. 6.
    Kielly, W. W. & Bradley, L. B. J. Biol. Chem. 218, 653–659 (1956)Google Scholar
  7. 7.
    Okamoto, Y & Sekine, T. J. Biochem. 98, 1143–1145 (1985)PubMedGoogle Scholar
  8. 8.
    Martin, J. B. & Doty, D. M. Anal. Chem. 21, 965–967 (1949)CrossRefGoogle Scholar
  9. 9.
    Kabsch, W., Mannherz, H. G., Suck, D., Pai, E. F. & Holmes, K. C. Nature 347, 37–44 (1990)PubMedCrossRefGoogle Scholar
  10. 10.
    Rayment, I., Rypniewski, W. R., Schmidt-Base, K., Smith, R., Tomchick, D. R., Benning, M. M., Winkelmann, D. A., Wesenberg, G. & Holden, H. M. Science 261, 50–58 (1993)PubMedCrossRefGoogle Scholar
  11. 11.
    Horiuti, K., Higuchi, H., Umazume, Y., Konishi, M., Okazaki, O. & Kurihara, S. J. Musc. Res. Cell Motil. 9, 156–164 (1988)CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1998

Authors and Affiliations

  • Yoh Okamoto
    • 1
  • Akihisa Hobo
    • 1
  • Koichi Kamisawada
    • 1
  1. 1.Department of Applied ChemistryMuroran Institute of TechnologyMuroran, Hokkaido 050Japan

Personalised recommendations